Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia

Circulation Research
S L ArcherE K Weir

Abstract

The cellular mechanisms that determine differences in reactivity of arteries of varying size and origin are unknown. We evaluated the hypothesis that there is diversity in the distribution of K+ channels between vascular smooth muscle (VSM) cells within a single segment of the pulmonary arteries (PAs) and that there are differences in the prevalence of these cell types between conduit and resistance arteries, which contribute to segmental differences in the vascular response to NO and hypoxia. Three types of VSM cells can be identified in rat PAs on the basis of their whole-cell electrophysiological properties- current density and the pharmacological dissection of whole-cell K+ current(I(K))-and morphology. Cells are referred to as "K(Ca), K(Dr), or mixed," acknowledging the type of K+ channel that dominates the IK: the Ca2+-sensitive (K(Ca)) channel, delayed rectifier (K(Dr)) channel, or a mixture of both. The three cell types were identified by light and electron microscopy. K(Ca) cells are large and elongated, and they have low current density and currents that are inhibited by tetraethylammonium (5 mmol/L) or charybdotoxin (100 nmol/L). K(Dr) cells are smaller, with a perinuclear bulge, but have high current density and cur...Continue Reading

References

Aug 1, 1992·The American Journal of Physiology·J D Horisberger
Apr 1, 1992·The American Journal of Physiology·J M PostE K Weir
Aug 1, 1991·Journal of Bioenergetics and Biomembranes·M L GarciaG J Kaczorowski
Oct 1, 1991·The American Review of Respiratory Disease·K HasunumaI F McMurtry
Mar 1, 1991·Journal of Neuroscience Methods·J RaeM Watsky
Nov 15, 1989·Biochemical and Biophysical Research Communications·S L ArcherE K Weir
Oct 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L N WalkerM A Reidy
Aug 1, 1986·Journal of Applied Physiology·M ShiraiI Ninomiya
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·S L ArcherE K Weir
Feb 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E K Weir, S L Archer
Oct 1, 1994·Pflügers Archiv : European journal of physiology·D GebremedhinD R Harder
Mar 8, 1995·Biochemical and Biophysical Research Communications·S AlbarwaniR Z Kozlowski
Jul 1, 1993·The American Journal of Physiology·B E RobertsonM T Nelson

❮ Previous
Next ❯

Citations

Jan 13, 2006·Pflügers Archiv : European journal of physiology·Leifu JiangMarion Delcroix
Dec 6, 2006·Pflügers Archiv : European journal of physiology·Lise RodatChristelle Guibert
Feb 15, 2012·The Journal of Physiological Sciences : JPS·Daling Zhu, Yajuan Ran
Oct 7, 1998·European Journal of Pharmacology·K Homer, J Wanstall
Jun 29, 1999·Respiration Physiology·J López-BarneoJ Ureña
Jul 29, 1999·Respiration Physiology·J P Ward, P I Aaronson
Aug 23, 2002·Pharmacology & Therapeutics·Alan Wickenden
Sep 12, 1998·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·N L Stephens, A J Halayko
May 14, 1999·General Pharmacology·K M McCullochA M Gurney
Oct 16, 1999·General Pharmacology·J P DumasM Dumas
Mar 3, 2001·Pathophysiology : the Official Journal of the International Society for Pathophysiology·J J. Dalle LuccaT B. Paiva
Oct 16, 2002·Vascular Pharmacology·Victoria P Korovkina, Sarah K England
Jul 20, 2002·Respiratory Physiology & Neurobiology·Larissa A ShimodaJ T Sylvester
Feb 1, 1997·British Journal of Pharmacology·R S Berman, T M Griffith
May 26, 2001·British Journal of Pharmacology·P D WeinbergM J Carrier
Apr 25, 2000·Clinical and Experimental Pharmacology & Physiology·J C WanstallB J Thomas
May 3, 2002·Clinical and Experimental Pharmacology & Physiology·Alison M GurneyFiona E J Kempsill
Nov 12, 2005·The New England Journal of Medicine·E Kenneth WeirStephen L Archer
Apr 5, 2005·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·William F Jackson
Jun 5, 1998·Clinical and Experimental Pharmacology & Physiology·T K CrilleyP A Bonnet
Apr 9, 1999·Thorax·S O Brij, A J Peacock
Feb 22, 2001·Annual Review of Physiology·J Lopez-BarneoP Ortega-Sáenz
Dec 24, 2010·American Journal of Physiology. Cell Physiology·Larissa A Shimoda, Jan Polak
Feb 23, 2007·American Journal of Physiology. Cell Physiology·Guiling ZhaoJonathan H Jaggar
Sep 2, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Candice D FikeJudy L Aschner
Apr 22, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Wenju LuJ T Sylvester
Dec 23, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Amy L FirthSergey V Smirnov
Jul 14, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Kathleen E DennisCandice D Fike
May 21, 2004·American Journal of Respiratory Cell and Molecular Biology·Zhigang HongAndrea Olschewski
Jul 23, 2011·American Journal of Respiratory Cell and Molecular Biology·Michael E YeagerK R Stenmark
Jan 24, 2003·American Journal of Respiratory Cell and Molecular Biology·Kurt R Stenmark, Sarah A Gebb

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.